B-lymphocyte antigen CD19 (CD19) Antibody (PerCP / Cyanine 5.5)
598€ (100 tests)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
B-lymphocyte antigen CD19 (CD19) Antibody (PerCP / Cyanine 5.5)
category
Primary Antibodies
provider
Abbexa
reference
abx347317
tested applications
FCM
Description
B-lymphocyte antigen CD19 (CD19) Antibody (PerCP/ Cyanine 5.5) is a PerCP/ Cyanine 5.5-conjugated Mouse Monoclonal antibody for B-lymphocyte antigen CD19 (CD19).
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | B-lymphocyte antigen CD19 (CD19) |
| Host | Mouse |
| Reactivity | Human |
| Recommended Dilution | FCM: 4 µl/100 µl whole blood or 106 cells. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Monoclonal |
| Conjugation | PerCP / Cyanine 5.5 |
| Clone ID | T665 |
| Purification | Purified by size-exclusion chromatography. |
| Size 1 | 100 tests |
| Form | Liquid |
| Tested Applications | FCM |
| Buffer | PBS, pH 7.4, 15 mM sodium azide. |
| Availability | Shipped within 5-12 working days. |
| Storage | Store at 2-8°C in the dark. Do not freeze. |
| Dry Ice | No |
| UniProt ID | P15391 |
| Gene ID | 930 |
| Alias | B4,CVID3,B-lymphocyte antigen CD19,B-lymphocyte surface antigen B4,Differentiation antigen CD19,T-cell surface antigen Leu-12 |
| Background | Antibody anti-CD19 |
| Status | RUO |
Descripción
Related Products
Human CD19(Cluster of Differentiation 19) ELISA Kit
Ver Producto
Mouse CD19(Cluster of differentiation 19) ELISA Kit
Ver Producto
anti- CD19 antibody
Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
Ver Producto